DNA methylation profiling of the human major histocompatibility complex: A pilot study for the Human Epigenome Project

PLoS Biology

Volumn 2, Issue 12, 2004, Pages

  Rakyan, Vardhman K ^a   Hildmann, Thomas ^b   Novik, Karen L ^a,d   Lewin, Jörn ^b   Tost, Jörg ^c   Cox, Antony V ^a   Andrews, T Dan ^a   Howe, Kevin L ^a   Otto, Thomas ^b   Olek, Alexander ^b   Fischer, Judith ^c   Gut, Ivo G ^c   Berlin, Kurt ^b   Beck, Stephan ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b EPIGENOMICS AG   (Germany)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN; CYTOSINE; MESSENGER RNA; SULFITE;

ARTICLE; CORRELATION ANALYSIS; DATA BASE; DESORPTION; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION; GENETIC VARIABILITY; GENOME; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; METHYLATION; PILOT STUDY; PIPELINE; TISSUE SPECIFICITY; CHEMISTRY; CPG ISLAND; EXON; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETIC EPIGENESIS; GENETICS; HUMAN GENOME PROJECT; INTERNET; INTRON; MASS SPECTROMETRY; METABOLISM; POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

CPG ISLANDS; CYTOSINE; DATABASES, GENETIC; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMAN GENOME PROJECT; HUMANS; INTERNET; INTRONS; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; PILOT PROJECTS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SULFITES; TISSUE DISTRIBUTION; VARIATION (GENETICS);

EID: 20044390368     PISSN: 15449173     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pbio.0020405     Document Type: Article

References (37)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
2. Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A 90: 11995-11999.
3. Beck S, Olek A, Walter J (1999) From genomics to epigenomics: A loftier view of life. Nat Biotechnol 17: 1144.
4. Besterman JM, McLeod R (2000) Targeting gene regulators for cancer therapy: Antisense inhibitors provide new sites for invention. Modern Drug Discov April: 53-58.
5. Bird A (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213.
6. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
7. Burch GH, Bedolli MA, McDonough S, Rosenthal SM, Bristow J (1995) Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development. Dev Dyn 203: 491-504.
8. Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, et al. (2001) Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7: 2727-2730.
9. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24: 132-138.
10. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, et al. (2003) Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 299: 1753-1755.
11. Dowell RD, Jokerst RM, Day A, Eddy SR, Stein L (2001) The distributed annotation system. BMC Bioinformatics 2: 7.
12. Eckhardt F, Beck S, Gut IG, Berlin K (2004) Future potential of the Human Epigenome Project. Expert Rev Mol Diagn 4: 609-618.
13. Garnier G, Circolo A, Colten HR (1995) Translational regulation of murine complement factor B alternative transcripts by upstream AUG codons. J Immunol 154: 3275-3282.
14. Grunau C, Clark SJ, Rosenthal A (2001) Bisulphite genomic sequencing: Systematic investigation of critical experimental parameters. Nucleic Acids Res 29: E65.
15. Horiuchi T, Macon KJ, Kidd VJ, Volanakis JE (1990) Translational regulation of complement protein C2 expression by differential utilization of the 5′-untranslated region of mRNA. J Biol Chem 265: 6521-6524.
16. International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409: 745-964.
17. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, et al. (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27: 31-39.
18. Kondo T, Bobek MP, Kuick R, Lamb B, Zhu X, et al. (2000) Whole-genome methylation scan in ICF syndrome: Hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Genet 9: 597-604.
19. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
20. Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C (2004) Quantitiative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. In press.
21. Lorincz MC, Schubeler D, Hutchinson SR, Dickerson DR, Groudine M (2002) DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol Cell Biol 22: 7572-7580.
22. Lubbert M (2000) DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: Clinical results and possible mechanisms of action. Curr Top Microbiol Immunol 249: 135-164.
23. MHC Sequencing Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401: 921-923.
24. Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, et al. (2003) The DNA sequence and analysis of human chromosome 6. Nature 425: 805-811.
25. Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, et al. (2001) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res 61: 8492-8497.
26. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, et al. (2004) An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: Interaction between genotype and epigenotype. Hum Mol Genet 13: 247-255.
27. Olek A, Oswald J, Walter J (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 24: 5064-5066.
28. Pham NV, Nguyen MT, Hu JF, Vu TH, Hoffman AR (1997) Dissociation of IGF2 and H19 imprinting in human brain. Brain Res 810: 1-8.
29. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, et al. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409: 928-933.
30. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: A laboratory manual. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. 999 p.
31. Sandovici I, Leppert M, Hawk PR, Suarez A, Linares Y, et al. (2003) Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum Mol Genet 12: 1569-1578.
32. Strichman-Almashanu LZ, Lee RS, Onyango PO, Perlman E, Flam F, et al. (2002) A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res 12: 543-554.
33. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, et al. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 99: 4465-4470.
34. Tost J, Schatz P, Schuster M, Berlin K, Gut IG (2003) Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res 31: e50.
35. Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, et al. (2003) A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 425: 832-836.
36. Yamada Y, Watanabe H, Miura F, Soejima H, Uchiyama M, et al. (2004) A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res 14: 247-266.
37. Yang Z, Shen L, Dangel AW, Wu LC, Yu CY (1998) Four ubiquitously expressed genes, RD (D6S45)-SKI2W (SKIV2L)-DOM3Z-RP1 (D6S60E), are present between complement component genes factor B and C4 in the class III region of the HLA. Genomics 53: 338-347.